The Traderszone Network

Published in TZ Latest News 29 May, 2015 by The TZ Newswire Staff

Why Shares of Heron Therapeutics, Inc. Skyrocketed Today

Shares of the clinical-stage biotech Heron Therapeutics gained over 45% today. Here’s why.